Chihiro Yamamoto

835 total citations
45 papers, 295 citations indexed

About

Chihiro Yamamoto is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Chihiro Yamamoto has authored 45 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 9 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Chihiro Yamamoto's work include Acute Myeloid Leukemia Research (12 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Immune Cell Function and Interaction (4 papers). Chihiro Yamamoto is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Immune Cell Function and Interaction (4 papers). Chihiro Yamamoto collaborates with scholars based in Japan and United States. Chihiro Yamamoto's co-authors include Ken Ohmine, Shin‐ichiro Fujiwara, Kaoru Hatano, Iekuni Oh, Kazuya Sato, Yoshinobu Kanda, Masahiro Ashizawa, Kazuo Muroi, Ryoko Yamasaki and Yasufumi Kawasaki and has published in prestigious journals such as Blood, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Chihiro Yamamoto

41 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chihiro Yamamoto Japan 10 111 70 68 56 42 45 295
Anca Bojan Romania 10 75 0.7× 53 0.8× 84 1.2× 36 0.6× 37 0.9× 39 310
Il-Kwon Lee South Korea 13 83 0.7× 198 2.8× 63 0.9× 34 0.6× 25 0.6× 43 389
Tung‐Liang Lin Taiwan 12 193 1.7× 132 1.9× 69 1.0× 38 0.7× 96 2.3× 32 372
Shaoling Zheng China 11 68 0.6× 162 2.3× 55 0.8× 63 1.1× 17 0.4× 25 367
Takeo Fujimoto Japan 11 178 1.6× 187 2.7× 67 1.0× 25 0.4× 31 0.7× 32 388
I Ben-Bassat Israel 7 242 2.2× 35 0.5× 84 1.2× 48 0.9× 52 1.2× 19 370
Shelly Pathak United Kingdom 9 70 0.6× 186 2.7× 29 0.4× 127 2.3× 24 0.6× 10 331
Lois W. Brüggemann Netherlands 10 88 0.8× 62 0.9× 30 0.4× 16 0.3× 41 1.0× 14 292
Katsutoshi Hara Japan 11 168 1.5× 52 0.7× 70 1.0× 23 0.4× 54 1.3× 23 436

Countries citing papers authored by Chihiro Yamamoto

Since Specialization
Citations

This map shows the geographic impact of Chihiro Yamamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chihiro Yamamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chihiro Yamamoto more than expected).

Fields of papers citing papers by Chihiro Yamamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chihiro Yamamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chihiro Yamamoto. The network helps show where Chihiro Yamamoto may publish in the future.

Co-authorship network of co-authors of Chihiro Yamamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Chihiro Yamamoto. A scholar is included among the top collaborators of Chihiro Yamamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chihiro Yamamoto. Chihiro Yamamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanabe, Takuya, et al.. (2025). Alleviating stress and perceived stigma in parents after febrile seizure in their children. Brain and Development. 47(5). 104445–104445.
2.
Toda, Yumiko, Masahiro Ashizawa, Takashi Ikeda, et al.. (2024). Tumor lysis syndrome in induction therapy for acute myeloid leukemia before the rasburicase era. International Journal of Hematology. 119(6). 660–666.
3.
4.
Fujiwara, Shin‐ichiro, Takashi Ikeda, Yumiko Toda, et al.. (2022). Effect of cumulative daunorubicin dose on cardiotoxicity after allogeneic stem cell transplantation. Leukemia Research. 121. 106951–106951. 5 indexed citations
5.
Yamamoto, Chihiro, et al.. (2021). Data-driven and Optimized Smart Cities Using Urban DTC. NTT technical review. 19(1). 45–51. 1 indexed citations
6.
Mashima, Kiyomi, Kazuya Sato, Takashi Ikeda, et al.. (2020). Dimethyl Fumarate Ameliorates Graft-Versus-Host Disease By Negatively Regulating Aerobic Glycolysis in Alloreactive T-Cells. Blood. 136(Supplement 1). 24–25. 1 indexed citations
7.
Ito, Shoko, Shin‐ichiro Fujiwara, Takashi Ikeda, et al.. (2019). Evaluation of thrombotic events in patients with immune thrombocytopenia. Annals of Hematology. 99(1). 49–55. 14 indexed citations
8.
Umino, Kento, Shin‐ichiro Fujiwara, Takashi Ikeda, et al.. (2018). Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement. Hematology. 23(8). 470–477. 20 indexed citations
9.
Kawasaki, Yasufumi, Kazuya Sato, Hiroko Hayakawa, et al.. (2018). Comprehensive Analysis of the Activation and Proliferation Kinetics and Effector Functions of Human Lymphocytes, and Antigen Presentation Capacity of Antigen-Presenting Cells in Xenogeneic Graft-Versus-Host Disease. Biology of Blood and Marrow Transplantation. 24(8). 1563–1574. 24 indexed citations
10.
Yamamoto, Chihiro, Hiroyasu Ogawa, Takahiro Fukuda, et al.. (2017). Impact of a Low CD34+ Cell Dose on Allogeneic Peripheral Blood Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 24(4). 708–716. 9 indexed citations
11.
Ito, Shoko, Shin‐ichiro Fujiwara, Kiyomi Mashima, et al.. (2017). Development of acute myeloid leukemia in patients with untreated chronic lymphocytic leukemia. Annals of Hematology. 96(5). 719–724. 9 indexed citations
12.
Umino, Kento, Shin‐ichiro Fujiwara, Kazuya Sato, et al.. (2017). High-Dose Methotrexate and Cytarabine-Based Multi-Agent Chemotherapy (Modified Bonn Protocol) for Systemic Lymphoma with CNS Involvement. Acta Haematologica. 137(2). 93–99. 3 indexed citations
13.
Yamamoto, Chihiro, et al.. (2016). Technology for Social Development of Accessibility Maps. NTT technical review. 14(7). 25–30. 3 indexed citations
15.
Tsukahara, Tamotsu, Koichi Kawakami, M. Iwasaki, et al.. (2014). The Tol2 transposon system mediates the genetic engineering of T-cells with CD19-specific chimeric antigen receptors for B-cell malignancies. Gene Therapy. 22(2). 209–215. 23 indexed citations
16.
Muroi, Kazuo, Shin‐ichiro Fujiwara, Raine Tatara, et al.. (2013). CD56 Expression in Normal Immature Granulocytes after Allogeneic Hematopoietic Stem Cell Transplantation. Journal of Clinical and Experimental Hematopathology. 53(3). 247–250. 6 indexed citations
17.
Tsukahara, Tomonori, Ken Ohmine, Chihiro Yamamoto, et al.. (2013). CD19 target-engineered T-cells accumulate at tumor lesions in human B-cell lymphoma xenograft mouse models. Biochemical and Biophysical Research Communications. 438(1). 84–89. 17 indexed citations
19.
Johkan, Masahumi, Tomoko Chiba, Satoshi Yamasaki, et al.. (2010). Seed Production Enhanced by Antiauxin in the pat-2 Parthenocarpic Tomato Mutant. Journal of the American Society for Horticultural Science. 135(1). 3–8. 7 indexed citations
20.
Yamamoto, Chihiro, et al.. (1996). Eosinophilia in premature infants: correlation with chronic lung disease. Acta Paediatrica. 85(10). 1232–1235. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026